BridgeBio Oncology Therapeutics Inc — Quarterly Dividends (NASDAQ:BBOT)

Financials

Key stats

Total common shares outstanding 23.51 M23.51 M23.51 M23.51 M79.99 M —

Valuation ratios

Enterprise value ————517.53 M — Price to earnings ratio ————-15.86 — Price to sales ratio ————49.31 — Price to cash flow ratio ————-3.85 — Price to book ratio ————0.39 — Enterprise value to EBITDA ratio ————— —

Profitability ratios

Return on assets % 0.01-0.24-0-0.110.09 -0.26 Return on equity % -0.6612.590.082.970.1 15.74 Return on invested capital % ——-4.98-2.29170.54 — Gross margin % 100100100100100 400 Operating margin % -4 895.07-629.46 K-99.03 K-96.79 K1 428.02 -823.85 K EBITDA margin % ————— — Net margin % 77.78 K-1.48 M-19.93 K-1.87 M1 299.56 -3.36 M

Liquidity ratios

Quick ratio ————— — Current ratio 16.1210.40.660.3313.33 24.72 Inventory turnover ————— — Asset turnover 00000.01 0.01

Solvency ratios

Debt to assets ratio ————— — Debt to equity ratio ————— — Long term debt to total assets ratio 00——0 — Long term debt to total equity ratio 00——0 —

Per share metrics

Operating cash flow per share -0-1.92-0.03-0.011.67 -0.29 EBIT per share ————— — EBITDA per share ————— — Total debt per share ————— — Cash per share 0.080.010.040.0310.77 10.85 Net current asset value per share 0.090.090.050.0410.95 11.13 Tangible book value per share -0.15-0.18-0.26-0.3110.27 9.52 Working capital per share 0.080.08-0.03-0.0710.12 10.11 Book value per share -0.15-0.18-0.26-0.3110.27 9.52